Biochemical Predictors of Early Onset Non-Alcoholic Fatty Liver Disease in Young Children with Obesity

다국어 초록 (Multilingual Abstract)

Background: The prevalence of metabolic syndrome (MS) and non-alcoholic fatty liver disease (NAFLD) and their associated risk factors are not well-established in young children with obesity. The purpose of this study was to evaluate the prevalence of early onset NAFLD and identify its biochemical predictors in obese children aged less than 10 years.
Methods: Anthropometric measurements, blood pressure, laboratory tests, and abdominal ultrasonography (USG) were performed in all subjects. National Cholesterol Education Program-Adult Treatment Panel III (NCEP-ATP III) criteria for MS diagnosis and liver enzymes and USG for NAFLD diagnosis were assessed.
Results: A total of 356 children with obesity (233 boys, 123 girls) were included, with 172 children age ≤ 10 years and 184 adolescents. The prevalence of MS was 23.3% in young children and 35.3% in adolescents (P = 0.020); while the prevalence of NAFLD was 36.0% and 70.7%, respectively (P = 0.001). In obese children aged 10 years or less, there were significant differences in levels of serum γ-glutamyltranspeptidase (γGT) (P < 0.001), triglycerides (P = 0.042), and homeostatic model assessment of insulin resistance (P < 0.001) between the non-NAFLD and the NAFLD group. Multivariate logistic regression analysis revealed significant increase in serum γGT and uric acid levels in young children.
Conclusion: Although MS and NAFLD were more prevalent in adolescents, young children also demonstrated MS and NAFLD as obesity-related complications. Elevated serum γGT and uric acid levels may serve as biochemical predictors in detecting NAFLD in young children with obesity before investigation with abdominal USG.

참고문헌 (Reference)

1 지수정, "소아 비알코올성 지방간질환의 병리 소견과 임상적, 영상학적소견의 상관성" 대한소화기학회 57 (57): 158-165, 2011

2 Lee KH, "Update on non-alcoholic fatty liver disease in children" 12 (12): S62-S71, 2009

3 Wan YP, "The prevalence of non-alcoholic fatty liver disease and its related risk factors in 1180 school children in Shanghai" 15 (15): 644-648, 2007

4 김준성, "The Role of Inflammatory Mediators in the Pathogenesis of Nonalcoholic Fatty Liver Disease" 대한소아소화기영양학회 15 (15): 74-78, 2012

5 Donnelly KL, "Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease" 115 (115): 1343-1351, 2005

6 Tahan V, "Serum gamma-glutamyltranspeptidase distinguishes non-alcoholic fatty liver disease at high risk" 55 (55): 1433-1438, 2008

7 Schwimmer JB, "SAFETY study: alanine aminotransferase cut off values are set too high for reliable detection of pediatric chronic liver disease" 138 (138): 1357-1364, 2010

8 Manco M, "Risk of severe liver disease in NAFLD with normal ALT levels: a pediatric report" 48 (48): 2087-2088, 2008

9 Sartorio A, "Predictors of non-alcoholic fatty liver disease in obese children" 61 (61): 877-883, 2007

10 Joung KH, "Predictors of growth in children based on 2007 Korean National Growth Charts" 53 (53): 832-838, 2011

11 Patton HM, "Pediatric nonalcoholic fatty liver disease: a critical appraisal of current data and implications for future research" 43 (43): 413-427, 2006

12 강기수, "Nutritional Counseling for Obese Children with Obesity-Related Metabolic Abnormalities in Korea" 대한소아소화기영양학회 20 (20): 71-78, 2017

13 Yang HR, "Noninvasive parameters and hepatic fibrosis scores in children with nonalcoholic fatty liver disease" 18 (18): 1525-1530, 2012

14 Matteoni CA, "Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity" 116 (116): 1413-1419, 1999

15 Marchesini G, "Nonalcoholic fatty liver disease: a feature of the metabolic syndrome" 50 (50): 1844-1850, 2001

16 Mencin AA, "Nonalcoholic fatty liver disease in children" 14 (14): 151-157, 2011

17 Vos MB, "NASPGHAN clinical practice guideline for the diagnosis and treatment of nonalcoholic fatty liver disease in children: recommendations from the Expert Committee on NAFLD (ECON) and the North American Society of Pediatric Gastroenterology, Hepatology and Nutrition (NASPGHAN)" 64 (64): 319-334, 2017

18 Strauss S, "Interobserver and intraobserver variability in the sonographic assessment of fatty liver" 189 (189): W320-W323, 2007

19 Hossain N, "Independent predictors of fibrosis in patients with nonalcoholic fatty liver disease" 7 (7): 1224-1229, 2009

20 Matthews DR, "Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man" 28 (28): 412-419, 1985

21 de Oliveira EP, "High plasma uric acid concentration: causes and consequences" 4 : 12-, 2012

22 Kinugasa A, "Fatty liver and its fibrous changes found in simple obesity of children" 3 (3): 408-414, 1984

23 Lonardo A, "Fasting insulin and uric acid levels but not indices of iron metabolism are independent predictors of non-alcoholic fatty liver disease. A case-control study" 34 (34): 204-211, 2002

24 Vajro P, "Diagnosis of nonalcoholic fatty liver disease inchildren and adolescents: position paper of the ESPGHAN Hepatology Committee" 54 (54): 700-713, 2012

25 Grundy SM, "Diagnosis and management of the metabolic syndrome: an American Heart Association/NationalHeart, Lung, and Blood Institute scientific statement: executive summary" 4 (4): 198-203, 2005

26 Kleiner DE, "Design and validation of a histological scoring system for nonalcoholic fatty liver disease" 41 (41): 1313-1321, 2005

27 Alberti KG, "Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation" 15 (15): 539-553, 1998

28 양혜란, "Comparison between a Pediatric Health Promotion Center and a Pediatric Obesity Clinic in Detecting Metabolic Syndrome and Non-Alcoholic Fatty Liver Disease in Children" 대한의학회 29 (29): 1672-1677, 2014

29 Bril F, "Clinical value of liver ultrasound for the diagnosis of nonalcoholic fatty liver disease in overweight and obese patients" 35 (35): 2139-2146, 2015

30 Koot BG, "Accuracy of prediction scores and novel biomarkers for predicting nonalcoholic fatty liver disease in obese children" 21 (21): 583-590, 2013